Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 27,471 | 28,198 | 20,182 | 20,245 | 23,261 |
| Operating Income | -27,471 | -28,198 | -20,182 | -20,245 | -23,261 |
| Interest Expense | 765 | 757 | 713 | 458 | 181 |
| Other Income | 162 | 93 | 39 | 140 | 466 |
| Pre-tax Income | -28,074 | -28,862 | -20,856 | -20,563 | -22,976 |
| Income Tax | 122 | 188 | 67 | 89 | 65 |
| Net Income Continuous | -28,196 | -29,050 | -20,923 | -20,652 | -23,041 |
| Net Income | $-28,196 | $-29,050 | $-20,923 | $-20,652 | $-23,041 |
| EPS Basic Total Ops | -11.00 | -11.60 | -9.00 | -12.60 | -14.20 |
| EPS Basic Continuous Ops | -10.98 | -11.44 | -9.06 | -12.66 | -14.29 |
| EPS Diluted Total Ops | -11.00 | -11.60 | -9.00 | -12.60 | -14.20 |
| EPS Diluted Continuous Ops | -10.98 | -11.44 | -9.06 | -12.66 | -14.29 |
| EBITDA(a) | $-26,935 | $-27,665 | $-19,720 | $-19,705 | $-22,770 |